Intuitive Biosciences

Intuitive Biosciences is a private, revenue-generating diagnostics and services company serving the biomedical research market, particularly in non-human primate studies. The company leverages its immunoassay development platform to offer custom assay development, validated screening tests, and multiplexed panels capable of measuring 1 to 100 markers per well. With a small, expert-led team, it provides end-to-end support from proof-of-concept to manufacturing, catering to research labs that require specialized infectious disease diagnostics. Its business model combines fee-for-service work with product sales, establishing a niche in the preclinical research supply chain.

Multiplexed immunoassay development platform capable of measuring 1-100 biomarkers per well, used for custom assay development and standardized test kits, with a focus on non-human primate (NHP) infectious disease screening.

Intuitive Biosciences competes in the multiplex immunoassay space against large platform providers like DiaSorin (Luminex), Bio-Rad, and Qiagen. Its differentiation lies in its deep specialization in NHP diagnostics and its hands-on, custom service approach, which larger firms may not offer. It also competes with other specialty CROs and testing labs serving the animal research market.